“Altered Threonine Tyrosine Kinase (TTK) Expression Is Associated With Adverse Clinical Outcomes in Breast Tumors: An in Silico Approach”. Research, Society and Development 12, no. 13 (November 27, 2023): e40121344285. Accessed June 28, 2025. https://ojs34.rsdjournal.org/index.php/rsd/article/view/44285.